跳至主要内容
临床试验/CTRI/2023/07/054621
CTRI/2023/07/054621尚未招募Unknown

Prolyl hydroxylase inhibitor(Desidustat) VS Erythropoiesis stimulating agent(Darbepoetin) in anemia of chronic kidney disease patients undergoing maintenance haemodialysis. - Not Applicable

Kalinga institute of medical sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Maintenance Haemodialysis Patients with Hb8-11 g/dl in chronic kidney disease.

排除标准

  • Patient with iron deficiency anemia .
  • History of Bleeding disorders.
  • Red blood cell transfusion within 8 weeks prior to enrollment.
  • History of previous or concurrent cancer.

研究者

相似试验

Desidustat VS Darbepoetin in anemia of chronic... | 临床试验